https://doi.org/10.4081/acbr.2023.243
Burden of cardiovascular disease risk factors among subjects with Type 2 Diabetes Mellitus in Southeastern Nigeria
Submitted: 26 October 2022
Accepted: 16 January 2023
Published: 12 July 2023
Accepted: 16 January 2023
Abstract Views: 110
PDF: 80
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Diabetes is associated with a high degree of cardiovascular morbidity and mortality. The co-existence of other cardiovascular risk factors alongside diabetes confers the cumulative risk of adverse outcomes. The prevalence of cardiovascular risk factors has been rising in sub-Saharan Africa, but their degree of co-existence with diabetes is not well known. The objective of this study was to determine the burden of cardiovascular risk factors in patients with Type 2 Diabetes Mellitus (T2DM) in a urban southeastern Nigerian population. This was a cross-sectional study consisting of consecutively recruited diabetic patients aged ≥40 years attending the diabetes clinic at Enugu State University of Science and Technology Teaching Hospital (ESUTH). Five cardiovascular risk factors were evaluated: Hypertension, overweight/obesity, cigarette smoking, physical inactivity, and poor glycemic control We studied 410 T2DM patients (31.5% male) with a mean age of 58.9 years and a mean duration of diabetes of 7.4 years. The most prevalent cardiovascular risk factor in the study was physical inactivity (69.5%), and 80.1% of respondents had 2 or more risk factors. Females had a significantly higher prevalence of physical inactivity, overweight/obesity, and poor glycemic control when compared to males (73% vs 62%; 73.3% vs 58.9%; 72.2% vs 60.5%, respectively). Our study has shown a high burden of cardiovascular risk factors in diabetic patients in an urban southeastern Nigerian population. Female diabetic subjects had a significantly higher prevalence of most of the cardiovascular risk factors except for smoking.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res ClinPract. 2018;138:271-281.
DOI: https://doi.org/10.1016/j.diabres.2018.02.023
Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376:1407-1418.
DOI: https://doi.org/10.1056/NEJMoa1608664
Rawshani A, Rawshani A, Franzén S, Sattar N, Eliasson B, Svensson et al. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2018; 379:633-644.
DOI: https://doi.org/10.1056/NEJMoa1800256
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263(21):2893-2898.
DOI: https://doi.org/10.1001/jama.263.21.2893
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703-713.
DOI: https://doi.org/10.1136/bmj.317.7160.703
Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998;316(7134):823-828.
DOI: https://doi.org/10.1136/bmj.316.7134.823
Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580-591.
DOI: https://doi.org/10.1056/NEJMoa0706245
Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383-393.
DOI: https://doi.org/10.1056/NEJMoa021778
Mensah GA. Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa. ProgCardiovasc Dis. 2013;56(3):240-250.
DOI: https://doi.org/10.1016/j.pcad.2013.10.014
Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019;73(5):e35-e66.
DOI: https://doi.org/10.1161/HYP.0000000000000087
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
DOI: https://doi.org/10.1001/jama.289.19.2560
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998;6(2):51S-209S.
American Diabetes Association. Standards of Medical Care in Diabetes-2018 Abridged for Primary Care Providers. Clin Diabetes. 2018;36(1):14-37.
DOI: https://doi.org/10.2337/cd17-0119
Larson JS, Winn M. Health policy and exercise: a brief BRFSS study and recommendations. Health PromotPract. 2010;11(2):268-274.
DOI: https://doi.org/10.1177/1524839908318287
WHO C. Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser. 2000 Jun 3;894(i-xii):1-253.
Adeloye D, Ige JO, Aderemi AV, Adeleye N, Amoo EO, Auta A, Oni G. Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis. BMJ open. 2017 May 1;7(5):e015424.
DOI: https://doi.org/10.1136/bmjopen-2016-015424
Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet. 2010;375(9733):2254-2266.
DOI: https://doi.org/10.1016/S0140-6736(10)60550-8
Mokta J, Mokta K, Ranjan A, Garg M. Prevalence of Cardiovascular Risk Factors among Diabetic Population and Awareness of Diabetes among Diabetic Patients: A Population Based Himalayan Study. J Assoc Physicians India. 2017;65(2):48-52.
Egede LE, Zheng D. Modifiable Cardiovascular Risk Factors in Adults with Diabetes: Prevalence and Missed Opportunities for Physician Counseling. Arch Intern Med. 2002;162(4):427–433.
DOI: https://doi.org/10.1001/archinte.162.4.427
Oda E. Metabolic syndrome: its history, mechanisms, and limitations. ActaDiabetol. 2012;49(2):89-95.
DOI: https://doi.org/10.1007/s00592-011-0309-6
Gæde P, Oellgaard J, Carstensen B, Rossing P, Lund-Andersen H, Parving HH, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia. 2016;59(11):2298-2307.
DOI: https://doi.org/10.1007/s00125-016-4065-6
Prevention C. National Diabetes Statistics Report. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services. 2020.
Gosmanov AR, Lu JL, Sumida K, Potukuchi PK, Rhee CM, Kalantar-Zadeh K, et al. Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes. J Hypertens. 2016;34(5):907-913.
DOI: https://doi.org/10.1097/HJH.0000000000000864
Passarella P, Kiseleva TA, Valeeva FV, Gosmanov AR. Hypertension Management in Diabetes: 2018 Update. Diabetes Spectr. 2018;31(3):218-224.
DOI: https://doi.org/10.2337/ds17-0085
Fadupin GT, Joseph EU, Keshinro OO. Prevalence of obesity among type 2 diabetics in Nigeria a case study of patients in Ibadan, Oyo State, Nigeria. Afr J Med Med Sci. 2004;33(4):381-384.
Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes MetabSyndrObes. 2013;6:327-338.
DOI: https://doi.org/10.2147/DMSO.S51325
Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med. 2006;12(1):75-80.
DOI: https://doi.org/10.1038/nm0106-75
Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes MetabSyndrObes. 2014;7:587-591.
DOI: https://doi.org/10.2147/DMSO.S67400
Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes. 2011;60(10):2441-2449.
DOI: https://doi.org/10.2337/db11-0425
Jelic K, Luzio SD, Dunseath G, Colding-Jorgsensen M, Owens DR. A cross-sectional analysis of NEFA levels following standard mixed meal in a population of persons with newly diagnosed type 2 diabetes mellitus across a spectrum of glycemic control. Diabetes. 2007;56:A234-A235.
Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177-189.
DOI: https://doi.org/10.1038/s41574-019-0310-7
Ford ES, Maynard LM, Li C. Trends in mean waist circumference and abdominal obesity among US adults, 1999-2012. JAMA. 2014;312(11):1151-1153.
DOI: https://doi.org/10.1001/jama.2014.8362
Sani MU, Wahab KW, Yusuf BO, Gbadamosi M, Johnson OV, Gbadamosi A, et al. Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population - a cross sectional study. BMC Res Notes. 2010;3:11.
DOI: https://doi.org/10.1186/1756-0500-3-11
Ojofeitimi EO, Adeyeye AO, Fadiora AO, Kuteyi AO, Faborode TG, Adegbenro CA et al. Awareness of obesity and its health hazard among women in a university community. Pakistan Journal of Nutrition. 2007; 6(5):502-505.
DOI: https://doi.org/10.3923/pjn.2007.502.505
Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008.Diabetes Care. 2011; 34:353–357.
DOI: https://doi.org/10.2337/dc10-0746
Zhao G, Ford ES, Li C, Mokdad AH. Compliance with physical activity recommendations in US adults with diabetes. Diabet Med. 2008;25(2):221-227.
DOI: https://doi.org/10.1111/j.1464-5491.2007.02332.x
Uloko AE, Musa BM, Ramalan MA, Gezawa ID, Puepet FH, Uloko AT, et al. Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. Diabetes Ther. 2018;9(3):1307-1316.
DOI: https://doi.org/10.1007/s13300-018-0441-1
González K, Fuentes J, Márquez JL. Physical Inactivity, Sedentary Behavior and Chronic Diseases. Korean J Fam Med. 2017;38(3):111-115.
DOI: https://doi.org/10.4082/kjfm.2017.38.3.111
Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Drug Healthc Patient Saf. 2014;6:155-165.
DOI: https://doi.org/10.2147/DHPS.S68786
Alzaheb RA, Altemani AH. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes MetabSyndrObes. 2018;11:15-21.
DOI: https://doi.org/10.2147/DMSO.S156214
Ufuoma C, Godwin YD, Kester AD, Ngozi JC. Determinants of Control among Persons with Type 2 Diabetes Mellitus in Niger Delta. Sahel Med J. 2016; 19:190-195.
DOI: https://doi.org/10.4103/1118-8561.196361
Ejike CE, Uka, NK, Nwachukwu SO. Diabetes and Prediabetes in Adult Nigerians: Prevalence, and Correlations of Blood Glucose Concentrations with Measures of Obesity. Afr. J. Biochem. Res. 2015:9(3) 55-60.
DOI: https://doi.org/10.5897/AJBR2015.0817
Onodugo O, Ezeala-AdikaibeB. , Anyim O, Onodugo P, AnyimI , Mbadiwe N, et al. Glycemic Control among Medical Outpatients in Enugu: A Cross Sectional Survey. Journal of Diabetes Mellitus. 2019;9:50-61.
DOI: https://doi.org/10.4236/jdm.2019.92006
Bash LD, Selvin E, Steffes M, Coresh J, Astor BC. Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med. 2008;168(22):2440-2447.
DOI: https://doi.org/10.1001/archinte.168.22.2440
Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016;37(3):278-316.
DOI: https://doi.org/10.1210/er.2015-1137
Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773-1779.
DOI: https://doi.org/10.1016/S0140-6736(09)60731-5
Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298(22):2654-2664.
DOI: https://doi.org/10.1001/jama.298.22.2654
Filion KB, Luepker RV. Cigarette smoking and cardiovascular disease: lessons from framingham. Glob Heart. 2013;8(1):35-41.
DOI: https://doi.org/10.1016/j.gheart.2012.12.005
Campagna D, Alamo A, Di Pino A, Russo C, Calogero AE, Purrello F, et al. Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetol Metab Syndr. 2019;11:85.
DOI: https://doi.org/10.1186/s13098-019-0482-2
Patel MS, Steinberg MB. In the Clinic. Smoking Cessation. Ann Intern Med. 2016;164(5):ITC33-ITC48.
DOI: https://doi.org/10.7326/AITC201603010
How to Cite
Uzoma Chukwunonso, O., Theophilus Ejiofor, U., Micheal Chinweuba, A., Titus Chukwubuzo, O., Thomas Obiora, N., & Ume, N. M. (2023). Burden of cardiovascular disease risk factors among subjects with Type 2 Diabetes Mellitus in Southeastern Nigeria. Annals of Clinical and Biomedical Research, 4(1). https://doi.org/10.4081/acbr.2023.243
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.